USE OF INHIBITORS OF EGFR-MEDIATED SIGNAL TRANSDUCTION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)/PROSTATIC HYPERTROPHY

摘要

The present invention relates to the use of specific EGF-receptor antagonistsfor preparing a pharmaceutical composition for the prevention and/ortreatment of benign prostatic hyperplasia and / or prostatic hypertrophy, amethod for the treatment or prevention of benign prostatic hyperplasia /prostatic hypertrophy comprising administering an EGF-receptor antagonist ofgroups (A), (B) or (C), optionally in combination with known compounds forthe treatment of benign prostatic hyperplasia / prostatic hypertrophy, as wellas associated pharmaceutical compositions.